Hernández FRA

Language: Spanish
References: 22
Page: 5-11
PDF size: 638.28 Kb.

ABSTRACT

In the last decades obesity has become a world epidemic. Obesity represents a risk factor for high-mortality conditions, as cardiovascular diseases, diabetes and cancer. This paper aims to update its main origin causes, as well as the relation between environment and genome in their development.

REFERENCES

1. Ahima RS. Obesity: Much Silence Makes a Mighty Noise. Gastroenterology. 2007;132:2085-2086.

2. Tolle V, Low MJ. In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice. Diabetes. 2008;57:86-94.

3. Coll AP, Farooqi IS, O’Rahilly S. The Hormonal Control of Food Intake. Cell. 2007;129:251-262.

4. Wren AM, Bloom SR. Gut Hormones and Appetite Control. Gastroenterology. 2007;132:2116-2130.

5. Jacquemond S, Reymond A, Zufferey F, Harewood L, Walters R G, Kutalik Z, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 11p11.2 locus. Nature. 2011;478:97-102.

6. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The Epidemiology of Obesity. Gastroenterology. 2007;132:2087-2102.

7. Niswender, KD, Beech BM. Obesity: Increasing Awareness of Novel Environmental Factors. Diabetes. 2008;57:1786-1787.

8. Friedman JM. A war on obesity, not the obese. Science. 2003;299:856-858.

9. Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, et al. Structural organization and chromosomal assignment of the human obese gene. J Biol Chem. 1995;270:27728-27733.

10. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18:213-215.

11. Winick JD, Stoffel M, Friedman JM. Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1. Genomics. 1996;36:221-222.

12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19:155-157.

13. Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, et al. A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3:135-140.

14. Yeo GS, Farooqi IS, Challis BG, Jackson RS, O’Rahilly S. The role of melanocortinsignalling in the control of body weight: evidence from human and murine genetic models. QJM. 2000;93:7-14.

15. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analices of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab. 2005;90:219-224.

16. Holder JL, Jr, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Molec Genet. 2000;9:101-108.

17. Faivre L, Cormier-Daire V, Lapierre JM, Colleaux L, Jacquemont S, et al. Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willi-like phenotype. (Letter) J Med Genet. 2002;39: 594-596.

18. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O’Rahilly S, Farooqi IS. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 2004;7:1187–1189.

19. Gray J, Yeo GSH, Cox JJ, Morton J, Adlam A-L R, Keogh JM, et al. Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) Gene. Diabetes. 2006;55:3366-3371.

20. Loos, RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9:246-50.

21. Wadden TA, Butryn ML, Wilson Ch. Lifestyle Modification for the Management of Obesity. Gastroenterology. 2007;132:2226-2238.

22. Bray GA, Ryan DH. Drug Treatment of the Overweight Patient. Gastroenterology. 2007;132:2239-2252.